Range
- - -
Vol / Avg.
-/3.2M
Div / Yield
-
52 Wk
2.09 - 5.14
Mkt Cap
499.2M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.51
Shares
174.5M
Outstanding
174.5M
Total Float
150.5M
load more
Sector: Health Care.Industry: Biotechnology
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-0.320-0.510 -0.1900
REV52.880M52.913M33.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKBAAkebia Therapeutics-0.34%499.2M

Akebia Therapeutics Questions & Anwsers

Q

How do I buy Akebia Therapeutics (AKBA) stock?

A

You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akebia Therapeutics's (AKBA) competitors?

Q

What is the target price for Akebia Therapeutics (AKBA) stock?

A

The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by Cantor Fitzgerald on March 8, 2021. The analyst firm set a price target for 8.00 expecting AKBA to rise to within 12 months (a possible 179.72% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Akebia Therapeutics (AKBA)?

A

The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $2.86 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Akebia Therapeutics (AKBA) pay a dividend?

A

There are no upcoming dividends for Akebia Therapeutics.

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A
Akebia Therapeutics’s Q3 earnings are confirmed for after-market on November 4, 2021.
Q

Is Akebia Therapeutics (AKBA) going to split?

A

There is no upcoming split for Akebia Therapeutics.

Q

What sector and industry does Akebia Therapeutics (AKBA) operate in?

A

Akebia Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.